Break Through Cancer will dole out $50 million to fund research on three difficult-to-treat malignancies: glioblastoma, ovarian cancer, and pancreatic cancer. The organization will facilitate interdisciplinary, interinstitutional work with “TeamLabs” to develop novel drugs and cancer treatment techniques.

You do not currently have access to this content.